Apatinib exhibits anti-leukemia activity in preclinical models of acute lymphoblastic leukemia

BACKGROUND: Acute lymphoblastic leukemia (ALL) is a clonal malignant disorder characterized by an uncontrolled proliferation of immature B or T lymphocytes. Extensive studies have suggested an involvement of angiogenesis signaling in ALL progression and resistance to treatment. Thus, targeting angio...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Manman, Zha, Jie, Jiang, Zhiwu, Jia, Xian, Shi, Yuanfei, Li, Peng, Chen, Xiao Lei, Fang, Zhihong, Du, Zhiqiang, Xu, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831852/
https://www.ncbi.nlm.nih.gov/pubmed/29490645
http://dx.doi.org/10.1186/s12967-018-1421-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831852/
https://www.ncbi.nlm.nih.gov/pubmed/29490645
http://dx.doi.org/10.1186/s12967-018-1421-y

Ejemplares similares